# Dysphagia Primary Care Initial Management & Referral - Category: chronic - Review status: reviewed (every claim checked against a document named on this page) - Sources: ACG Clinical Guideline: Diagnosis and Management of Esophageal Motility Disorders 2020 · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph) - Verified date: 2026-08 ## Verified against - Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph) - Dysphagia - disease-level clinical article (dysphagia-referral-clinical.txt) ## Treatment metadata - Omeprazole — 20 mg — oral.solid - Referral & safety-netting (no drug therapy) ## Complete treatment card ```text DYSPHAGIA PRIMARY CARE INITIAL MANAGEMENT & REFERRAL Sources: ACG Clinical Guideline: Diagnosis and Management of Esophageal Motility Disorders 2020 · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph) Review status: REVIEWED against Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph), Dysphagia - disease-level clinical article (dysphagia-referral-clinical.txt) (2026-08) IS IT THIS? - reference only, to read alongside your own examination SYMPTOMS - what the patient reports (5) - Solid-food dysphagia points toward a mechanical narrowing such as an esophageal web or ring [difficulty swallowing · stricture] - Steadily worsening dysphagia raises concern for a progressive stricture or malignancy [difficulty swallowing · stricture] - Liquid dysphagia points to a motility problem like achalasia or systemic sclerosis [difficulty swallowing] - Undigested-food regurgitation with hoarseness, bad breath, and throat fullness points to a Zenker diverticulum [diverticulosis · hoarseness · regurgitation] - A smoking or alcohol history, with or without unintended weight loss, raises suspicion for malignancy SIGNS - what you find (1) - Exam may show poor dentition or gum disease, abnormal lip closure, mucosal change, or neurological signs TESTS (5) - A bedside clinical swallow evaluation is the initial test but can miss over half of significant aspiration - Videofluoroscopic swallow study visualizes bolus passage to assess swallow physiology and aspiration risk - FEES passes an endoscope through the nose to directly view the pharynx and larynx during swallowing - Barium esophagogram is a simple, low-cost first-line test for esophageal dysphagia - High-resolution manometry helps diagnose achalasia, diffuse esophageal spasm, and jackhammer esophagus IF NOT THIS - what else fits (12) - Benign esophageal stricture - Cerebrovascular accident (stroke) - Diffuse esophageal spasm - Eosinophilic esophagitis - Esophageal malignancy - Esophageal webs and rings - Gastroesophageal reflux disease (GERD) - Hiatal hernia is on the differential - Multiple sclerosis is on the differential - Parkinson disease is on the differential - Zenker diverticulum is on the differential - Dysphagia lusoria, a childhood form from vascular compression of the esophagus such as an aberrant right subclavian artery or double aortic arch Source StatPearls "Dysphagia" - disease-level clinical article Status traced to the source above 1. OMEPRAZOLE [1st line] Adult 20-40 mg once daily 30 minutes before breakfast - Until urgent endoscopic evaluation Peds Specialist pediatric gastroenterology referral required for paediatric dysphagia Source Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph) Why Empiric trial for peptic stricture / reflux dysphagia while urgent upper GI endoscopy referral is arranged Caution URGENT REFERRAL MANDATORY: Dysphagia is a red-flag symptom requiring urgent upper GI endoscopy to exclude esophageal carcinoma or stricture. Do not delay diagnostic endoscopy while prescribing PPI. Advise soft/liquid diet and thorough chewing while awaiting evaluation. Egypt OMEGASTAZOLE 20MG 14 CAPS. RIVA PHARMA S... 18.00 EGP (1.29/unit) OMEPRAL 20MG 14 CAPS. MEMPHIS 32.00 EGP (2.29/unit) RISEK 20 MG 28 CAPS. JULPHAR 75.00 EGP (2.68/unit) OMISEC 20MG 14CAPS. THE UNITED PH... 42.00 EGP (3.00/unit) EPIRAZOLE 20MG 14CAPS. EIPICO 44.00 EGP (3.14/unit) OMEPAK 20 MG 14 CAPS. SEDICO 50.00 EGP (3.57/unit) RISEK 20 MG 14 CAPS. JULPHAR 57.00 EGP (4.07/unit) NAPIZOLE 20MG 14 CAPS. GLOBAL NAPI P... 62.00 EGP (4.43/unit) 2. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY) [1st line] Adult Source Dysphagia - disease-level clinical article (dysphagia-referral-clinical.txt) Why Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen. Caution RED FLAG - Alarm features of malignancy (weight loss, bleeding, smoking/alcohol history) accompanying dysphagia require urgent head/neck or GI evaluation, not just an empiric PPI trial. RED FLAG - Progressive (vs intermittent) dysphagia is a specific red flag suggesting stricture or malignancy rather than a benign/motility cause. RED FLAG - Oropharyngeal dysphagia (difficulty initiating swallowing, coughing/choking, nasal regurgitation - often neurological, eg stroke) must be distinguished from esophageal dysphagia before treatment, since it carries aspiration risk and needs speech-pathology/ENT/neuro referral rather than a GI-endoscopy-linked PPI trial. Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy. ``` --- Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement. [Privacy policy](/privacy)